[1] ANTONOV L. Tautomerism:methods and theories[M]. Weinheim:Wiley-VCH, 2003. [2] ELGUERO J, KATRITZKY A R, DENISKO O V. Tautomerism of heterocycles[M]. New York:Academic Press, 1976. [3] SMITH M B, MARCH J. March's advanced organic chemistry:reactions, mechanisms, and structure[M]. 6th ed. New York:Wiley-Interscience, 2007. [4] WU Z W, ZHANG R, RONG Z M. Azo-hydrazone tautomerism of azo dyes[J]. J Chem Ind Eng, 2015, 66(1):52-59. 吴祖望, 张蓉, 荣泽明. 论偶氮染料的偶氮-腙互变异构[J]. 应用化学, 2015, 66(1):52-59. [5] MASAND V H, MAHAJAN D T, HADDA T B, et al. Does tautomerism influence the outcome of QSAR modeling?[J]. Med Chem Res, 2014, 23:1742-1757. [6] IVANOVA D, DENEVA V, NEDELTCHEVA D, et al. Tautomeric transformations of piroxicam in solution:a combined experimental and theoretical study[J]. RSC Adv, 2015, 5(40):31852-31860. [7] CRUZ-CABEZA A J, GROOM C R. Identification, classification and relative stability of tautomers in the Cambridge structural database[J]. CrystEngComm, 2011, 13(1):93-98. [8] BAUER M, HARRIS R K, RAO R C, et al. NMR study of desmotropy in Irbesartan, a tetrazole-containing pharmaceutical compound[J]. J Chem Soc, Perkin Trans, 1998, 2(3):475-482. [9] KUMAR S S, NANGIA A. A solubility comparison of neutral and zwitterionic polymorphs[J]. Cryst Growth Des, 2014, 14(4):1865-1881. [10] TOTHADI S, BHOGALA B R, GORANTLA A R, et al. Triclabendazole:an intriguing case of co-existence of conformational and tautomeric polymorphism[J]. Chem Asian J, 2012, 7(2):330-342. [11] MIRMEHRABI M, ROHANI S, MURTHY K S K, et al. Characterization of tautomeric forms of ranitidine hydrochloride:thermal analysis, solid-state NMR, X-ray[J]. J Cryst Growth, 2004, 260(3-4):517-526. [12] WANG X J, KONG M M, LI D X, et al. Stanozolol-aromatic carboxylic acid crystalline complexes:flexible tautomeric/ionization states and supramolecular synthons[J]. Cryst Eng Comm, 2019, DOI:10.1039/C8CE01439F. [13] HAMAZAKI H, HOSOMI, H, TAKEDA, S, et al. 2-Pyridinecarboxylic acid[J]. Acta Cryst Sect C:Cryst Struct Commun, 1998, 54(10):IUC9800049. [14] LUO C, LIANG W D, CHEN X, et al. Pharmaceutical cocrystals of naringenin with improved dissolution performance[J]. CrystEngComm, 2018, 20(22):3025-3033. [15] GRANT R S, COGGAN S E, SMYTHE G A. The physiological action of picolinic acid in the human brain[J]. Int J Tryptophan Res, 2009, 2(2):71-79. [16] LOU X B, SHEN M, LI C, et al. Reduction of the 13C cross-polarization experimental time for pharmaceutical samples with long T1 by ball milling in solid-state NMR[J]. Solid State Nucl Magn Reson, 2018, 94(16):20-25. [17] WANG L, LUO M, LI J H, et al. Sweet theophylline cocrystal with two tautomers of acesulfame[J]. Cryst Growth Des, 2015, 15(6):2574-2578. [18] LI J H, FU X, LI J Y, et al. Quinine acesulfamates[J]. Cryst Growth Des, 2016, 17(1):58-66. [19] YUAN Y, WANG L, LI D X, et al. How many parameters can affect the solid form of cocrystallization products in mechanochemical reactions? a case study[J]. Cryst Growth Des, 2018, 18(12):7244-7247. [20] SHELDRICK G M. Crystal structure refinement with SHELXL[J]. Acta Cryst Sect C:Struct Chem, 2015, 71(1):3-8. [21] SCHAEFER J, SEFCIK M D, STEJSKAL E O, et al. Total suppression of sidebands in CPMAS C-13 NMR[J]. J Magn Reson, 1982, 49(2):341-345. [22] BALIMANN G E, GROOMBRIDGE C J, HARRIS R K, et al. Chemical applications of high-resolution 13C NMR spectra for solids[J]. Philos Trans R Soc Lond A, 1981, 299:643-663. [23] CLARK S J, SEGALL M D, PICKARD C J, et al. First principles methods using CASTEP[J]. Z Kristallogr, 2005, 220(5-6):567-570. [24] STEED K M, STEED J W. Packing problems:high Z' crystal structures and their relationship to cocrystals, inclusion compounds, and polymorphism[J]. Chem Rev, 2015, 115(8):2895-2933. [25] HOSER A A, SOVAGO I, LANZA A, et al. A crystal structure prediction enigma solved:the gallic acid monohydrate system-surprises at 10 K[J]. Chem Commun, 2017, 53(5):925-928. [26] ZHENG A M, LIU S B, DENG F. 13C shielding tensors of crystalline amino acids and peptides:theoretical predictions based on periodic structure models[J]. J Comput Chem, 2009, 30(2):222-235. [27] TATTON A S, PHARM T N, VOGT F G, et al. Probing hydrogen bonding in cocrystals and amorphous dispersions using 14N-1H HMQC solid-state NMR[J]. Mol Pharmaceutics, 2013, 10(3):999-1007. [28] JOSEPH A, ALVES J S R, BERNARDES C E S, et al. Tautomer selection through solvate formation:the case of 5-hydroxynicotinic acid[J]. CrystEngComm, 2019, 21(13):2220-2233. |